REVATIS SA has a total of 22 patent applications. It increased the IP activity by 133.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are POLYBIOCEPT AB, DIABCELL PTY LTD and IMMUNICUM AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Argentina | 1 | |
#9 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | IT methods for management | |
#7 | Control |
# | Name | Total Patents |
---|---|---|
#1 | Serteyn Didier | 20 |
#2 | Ceusters Justine | 20 |
#3 | Dedry Claude | 4 |
#4 | Donolato Tony | 4 |
#5 | Decubber Denis | 4 |
#6 | Neyt Philippe | 4 |
Publication | Filing date | Title |
---|---|---|
US2019271963A1 | Multi-Site Production System And Method | |
EP3388513A1 | Method of obtaining differentiated cells from muscle derived progenitor cells | |
EP3388511A1 | New uses of mammalian muscle derived stel cells |